Weight Loss

Semaglutide works by activating the body's GLP-1 receptors. This helps the body to lower blood sugar levels and also helps to increase the production of insulin, which leads to reduced appetite and increased feelings of satiety (fullness).

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally used to manage type 2 diabetes. Recent research shows it’s also highly effective for weight loss. It works by mimicking a natural hormone in your body that helps regulate your appetite and blood sugar levels. In studies, patients taking semaglutide lost significantly more weight than those using other weight loss methods.

The cost of these weight loss services includes consultation, lab work, and medication. The program is structured as a monthly subscription, with prices for semaglutide and tirzepatide treatments available on a monthly basis. Discounts are offered for longer commitments.

‍

Patients can expect a comprehensive approach including the delivery of medications like semaglutide or tirzepatide, routine check-ins for progress monitoring, and continuous support from healthcare providers.

Procedures related to these weight loss services might include additional lab testing, dietary counseling, exercise planning, and regular medical check-ups to ensure overall health and well-being during the weight loss process.

These services are aimed at providing a sustainable and medically supervised approach to weight loss. The medications used, semaglutide and tirzepatide, help regulate appetite and blood sugar levels, contributing to weight reduction.

At ClearMD, our medically supervised weight loss services include the use of semaglutide and tirzepatide, two medications known for their efficacy in weight management. These services are complemented by counseling and support to ensure a holistic approach to weight loss.

Tirzepatide is an anti-diabetic medication that activates GLP-1 and GIP receptors, which leads to better control of blood sugar. In recent studies, tirzepatide has been shown to provide substantial, safe and clinically meaningful weight loss.

Ongoing support and regular consultations are part of the follow-up process to monitor progress and make necessary adjustments. Recovery, in this context, relates to the gradual and sustained achievement of weight loss goals.

As with any medical treatment, there are potential risks, such as side effects from the medications used. It’s important to discuss these with your provider and consider your personal health history.

ClearMD is proud to offer complimentary initial bloodwork, with results promised to you in under 24 hours. Our initial screening includes a comprehensive metabolic panel, complete blood count, hemoglobin A1C, and thyroid panel.

There is basically no difference between semaglutide, Wegovy and Mounjaro. While Mounjaro and Wegovy are brand names of a specific distribution, semaglutide is the generic name. While the dose or the way that the medication is administered may be different, they are both GLP-1 receptor agonists that are useful in treating obesity.

Usually semaglutide is administered through subcutaneous (under the skin) injection that occurs weekly, but this can vary depending on a particular patient’s medical situation.

Preparation for these services typically involves scheduling a consultation, either virtually or in-person, to determine candidacy. Initial lab work will be conducted to assess your health status. Once you eligibility for the program has been confirmed you will be placed on a individual plan where you will meet with a provider regularly to continue meeting your weight loss goals. Please note that the fee for the initial consult for self-pay patients is $199.